Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

When people think about diet and cancer, they often connect it to diseases like liver or pancreatic cancer. Red meat, alcohol ...

Clinical trials to develop a lung cancer vaccine to treat or prevent the most deadly form of cancer in the U.S. could be ...

A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have ...

Life science firm Nuvation Bio raised $250 million to bring its novel lung cancer therapy to market and help it reach ...

For cancers of organs like the liver, the long-term impact of our diet has been well studied—so much so that we have guidance ...

More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a ...

Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

The first patient with small cell lung cancer has been dosed in a trial of peluntamig (PT217) combined with chemotherapy.

The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.

The FDA cleared the investigational new drug application for MRANK-106, a dual WEE1/YES1 kinase inhibitor, targeting advanced ...

Many cancer patients seeking treatment abroad are surprised to find that the same medications and therapies are available in ...